# BLS Labs LLC – FDA 483, Jun 17, 2026

Source: https://www.keypedia.com/records/483/bls-labs-llc/69c32698-1d1e-4c8b-a640-970aa9dcd4b4

> FDA 483 for BLS Labs LLC on June 17, 2026. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: BLS Labs LLC
- Inspection Date: 2026-06-17
- Product Type: biologics
- Office Name: Denver District Office
- Summary: An FDA inspection of BLS Labs LLC, a tissue manufacturer in Mesa, AZ, revealed a significant deficiency in their complaint handling system. The firm's complaint files lacked sufficient information for proper review and evaluation, failing to determine if reported patient infections from tissue allografts represented a trend. The investigation into a consumer complaint regarding multiple patient infections was found to be inadequate in scope and failed to document identified trends.

## Related Officers

- [Garrad R. Poole](https://www.keypedia.com/people/garrad-r-poole/7fc97953-367e-459b-905d-25efe6ec39d2)
- [Investigator](https://www.keypedia.com/people/paul-m-chefor/96bea4a8-b1ee-4870-ae8b-24794c67da21)

Company: https://www.keypedia.com/companies/bls-labs-llc/1a01f0f8-8122-4ae7-a84e-51bd4b180822

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face